Article Details
Retrieved on: 2018-02-27 23:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Renaissance Technologies</b> LLC lifted its stake in Regulus Therapeutics by 215.7% during the 4th quarter. <b>Renaissance Technologies</b> LLC now owns 137,589 shares of the biopharmaceutical company's stock worth $143,000 after acquiring an additional 94,000 shares in the last quarter. GSA Capital ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here